Zhang Q - Search Results

1

Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat.

Wang XQ, Fan JM, Liu YO, Zhao B, Jia ZR, Zhang Q. Wang XQ, et al. Among authors: zhang q. Int J Pharm. 2011 Oct 31;419(1-2):339-46. doi: 10.1016/j.ijpharm.2011.08.003. Epub 2011 Aug 9. Int J Pharm. 2011. PMID: 21843612

2

An alternative paclitaxel microemulsion formulation: hypersensitivity evaluation and pharmacokinetic profile.

He L, Wang GL, Zhang Q. He L, et al. Among authors: zhang q. Int J Pharm. 2003 Jan 2;250(1):45-50. doi: 10.1016/s0378-5173(02)00478-7. Int J Pharm. 2003. PMID: 12480272

3

A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.

Jia Z, Lin P, Xiang Y, Wang X, Wang J, Zhang X, Zhang Q. Jia Z, et al. Among authors: zhang q, zhang x. Eur J Pharm Biopharm. 2011 Sep;79(1):126-34. doi: 10.1016/j.ejpb.2011.05.009. Epub 2011 May 30. Eur J Pharm Biopharm. 2011. PMID: 21658449

4

Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo.

Zhang JY, He B, Qu W, Cui Z, Wang YB, Zhang H, Wang JC, Zhang Q. Zhang JY, et al. Among authors: zhang q, zhang h. J Microencapsul. 2011;28(6):528-36. doi: 10.3109/02652048.2011.590614. Epub 2011 Jun 27. J Microencapsul. 2011. PMID: 21702701

5

The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.

Zhang Y, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. Zhang Y, et al. Among authors: zhang q, zhang h, zhang x. Biomaterials. 2012 Jan;33(2):679-91. doi: 10.1016/j.biomaterials.2011.09.072. Epub 2011 Oct 22. Biomaterials. 2012. PMID: 22019123

6

Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against Parkinson's disease in the MPTP-induced mice model.

Xiang Y, Wu Q, Liang L, Wang X, Wang J, Zhang X, Pu X, Zhang Q. Xiang Y, et al. Among authors: zhang q, zhang x. J Drug Target. 2012 Jan;20(1):67-75. doi: 10.3109/1061186X.2011.595490. J Drug Target. 2012. PMID: 22149216

7

Mesoporous silica nanoparticles for increasing the oral bioavailability and permeation of poorly water soluble drugs.

Zhang Y, Wang J, Bai X, Jiang T, Zhang Q, Wang S. Zhang Y, et al. Among authors: zhang q. Mol Pharm. 2012 Mar 5;9(3):505-13. doi: 10.1021/mp200287c. Epub 2012 Feb 1. Mol Pharm. 2012. PMID: 22217205

8

Peptide PHSCNK as an integrin α5β1 antagonist targets stealth liposomes to integrin-overexpressing melanoma.

Dai W, Yang T, Wang Y, Wang X, Wang J, Zhang X, Zhang Q. Dai W, et al. Among authors: zhang q, zhang x. Nanomedicine. 2012 Oct;8(7):1152-61. doi: 10.1016/j.nano.2012.01.003. Epub 2012 Jan 31. Nanomedicine. 2012. PMID: 22306158

9

A novel lanreotide-encoded micelle system targets paclitaxel to the tumors with overexpression of somatostatin receptors.

Zheng N, Dai W, Du W, Zhang H, Lei L, Zhang H, Wang X, Wang J, Zhang X, Gao J, Zhang Q. Zheng N, et al. Among authors: zhang q, zhang h, zhang x. Mol Pharm. 2012 May 7;9(5):1175-88. doi: 10.1021/mp200464x. Epub 2012 Mar 30. Mol Pharm. 2012. PMID: 22435704

10

A cremophor-free self-microemulsified delivery system for intravenous injection of teniposide: evaluation in vitro and in vivo.

He S, Cui Z, Mei D, Zhang H, Wang X, Dai W, Zhang Q. He S, et al. Among authors: zhang q, zhang h. AAPS PharmSciTech. 2012 Sep;13(3):846-52. doi: 10.1208/s12249-012-9809-0. Epub 2012 May 30. AAPS PharmSciTech. 2012. PMID: 22644709 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70,011 results

Search Page

Filters